Article information
Full text is only aviable in PDF
References
[1]
VS Peña, M Miravitlles, R Gabriel, CA Jiménez-Ruiz, C Villasante, JF Masa, et al.
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.
Chest, 118 (2000), pp. 981-989
[2]
NR Anthonisen, MA Skeans, RA Wise, J Manfreda, RE Kanner, JE Connett.
The effects of a smoking cessation intervention on 14.5year mortality: a randomized clinical trial.
Ann Intern Med, 142 (2005), pp. 233-239
[3]
D Gorecka, K Gorzelak, P Sliwinski, M Tobiasz, J Zielinski.
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.
Thorax, 52 (1997), pp. 674-679
[4]
DM Skillrud, KP Offord, RD Miller.
Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.
Ann Intern Med, 105 (1986), pp. 503-507
[5]
LH Kuller, J Ockene, E Meilahn, KH Svendsen.
Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
Am J Epidemiol, 132 (1990), pp. 265-274
[6]
A Nomura, GN Stemmermann, PH Chyou, EB Marcus, AS Buist.
Prospective study of pulmonary function and lung cancer.
Am Rev Respir Dis, 144 (1991), pp. 307-311
[7]
D Baliunas, J Patra, J Rehm, S Popova, M Kaiserman, B Taylor.
Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy.
Chronic Dis Can, 27 (2007), pp. 154-162
[8]
DD Sin, NR Anthonisen, JB Soriano, AG Agustí.
Mortality in COPD: role of comorbidities.
Eur Respir J, 28 (2006), pp. 1245-1257
[9]
ST Mayne, J Buenconsejo, DT Janerich.
Previous lung disease and risk of lung cancer among men and women nonsmokers.
Am J Epidemiol, 149 (1999), pp. 13-20
[10]
DM Mannino, SM Aguayo, TL Petty, SC Redd.
Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up.
Arch Intern Med, 163 (2003), pp. 1475-1480
[11]
A Papi, G Casoni, G Caramori, I Guzzinati, P Boschetto, F Ravenna, et al.
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma.
Thorax, 59 (2004), pp. 679-681
[12]
KJ O'Byrne, AG Dalgleish.
Chronic immune activation and inflammation as the cause of malignancy.
Br J Cancer, 85 (2001), pp. 473-483
[13]
V Chiarugi, L Magnelli, O Gallo.
Cox-2, iNOS and p53 as playmakers of tumor angiogenesis [review].
Int J Mol Med, 2 (1998), pp. 715-719
[14]
AI Papaioannou, K Kostikas, P Kollia, KI Gourgoulianis.
Clinical implications for vascular endothelial growth factor in the lung: friend or foe? [review].
Respir Res, 7 (2006), pp. 128
[15]
N Ilhan, N Ilhan, F Deveci.
Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types.
Clin Biochem, 37 (2004), pp. 840-845
[16]
V Ludovini, V Gregorc, L Pistola, Z Mihaylova, I Floriani, S Darwish, et al.
Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Lung Cancer, 46 (2004), pp. 77-85
[17]
W MacNee.
Pathogenesis of chronic obstructive pulmonary disease.
Proc Am Thorac Soc, 2 (2005), pp. 258-266
[18]
E Barreiro, J Gea, JM Corominas, SN Hussain.
Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol, 29 (2003), pp. 771-778
[19]
E Barreiro, J Gea, G Matar, SN Hussain.
Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol, 33 (2005), pp. 636-642
[20]
E Barreiro, B De la Puente, J Minguella, JM Corominas, S Serrano, SN Hussain, et al.
Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 171 (2005), pp. 1116-1124
[21]
B Pignatelli, CQ Li, P Boffetta, Q Chen, W Ahrens, F Nyberg, et al.
Nitrated and oxidized plasma proteins in smokers and lung cancer patients.
Cancer Res, 61 (2001), pp. 778-784
[22]
FA Masri, SA Comhair, T Koeck, W Xu, A Janocha, S Ghosh, et al.
Abnormalities in nitric oxide and its derivatives in lung cancer.
Am J Respir Crit Care Med, 172 (2005), pp. 597-605
Copyright © 2008. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
